Search over 3,000 reports

    Acute Respiratory Distress Syndrome (ARDS) - Market Insights, Epidemiology and Market Forecast-2023

    Acute Respiratory Distress Syndrome (ARDS) - Market Insights, Epidemiology and Market Forecast-2023
    Date: Nov, 2017
    Type: Pharmaceutical Industry Report
    Pages: 62
    Geography: Global
    Delivery Timeline: 24 Hours
    SKU: DIMI0011
    DelveInsight's?Acute Respiratory Distress Syndrome - Market Insights, Epidemiology and Market Forecast-2023'report provides an overview of the Acute Respiratory Distress Syndrome along with the epidemiology and the market scenarioin the 7MM - United States, EU5 (Germany, France, Spain Italy , United Kingdom) and Japan.
    The Report provides a comprehensive review of the market trends, drivers, barriers, key company profiles including its business and product developments.
    It includes historical and forecasted epidemiological data for Acute Respiratory Distress Syndrome in 7MM.Our epidemiology forecast covers the incident population as well as the subtype specific population having Acute Respiratory Syndrome.
    The report also covers the detailed market size forecast for 7MM.The market size of Acute Respiratory Distress Syndromein 7MM is expected to grow at a compound annual growth rate (CAGR) of 4.36% for the forecast period i.e., 2013-2023.
    Acute Respiratory Distress Syndrome is a life-threatening disease in which air-sacs in alveoli are filled with fluid and lower amount of oxygen in the blood. This lower supply of oxygen in the blood causes inflammation throughout the lungs leading to Acute Respiratory Disease Syndrome (ARDS).
    Key Coverage and Benefits:
    The report will help in developing business strategies by understanding the trends shaping and driving the global Acute Respiratory Distress Syndrome market.
    Organize sales and marketing efforts by identifying the best opportunities for Acute Respiratory Distress Syndrome in US, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan.
    To understand the future market competition in the global Acute Respiratory Distress Syndrome market and Insightful review of the key market drivers and barriers.
    To understand the regulatory scenario in major markets.
    The Report includes detailed global historical and forecasted Acute Respiratory Distress Syndrome market covering United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2023.
    The Report also covers the epidemiology of Acute Respiratory Distress Syndrome in 7MM- United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2023.
    Report Introduction
    Acute Respiratory Distress Syndrome (ARDS)
    Overview
    Stages
    Signs and Symptoms
    Complications
    Pathophysiology
    Etiology
    Risk factors
    Diagnosis
    Treatment
    Epidemiology of Acute Respiratory Distress Syndrome (ARDS) in 7MM
    United States
    Incident cases of Acute Respiratory Distress Syndrome in United States
    Sub-type (Mild and Moderate) specific incident cases of Acute Respiratory Distress Syndrome in United States
    EU5
    United Kingdom
    Incident cases of Acute Respiratory Distress Syndrome in United Kingdom
    Sub-type (Mild and Moderate) specific incident cases of Acute Respiratory Distress Syndrome in United Kingdom
    Germany
    Incident cases of Acute Respiratory Distress Syndrome in Germany
    Sub-type (Mild and Moderate) specific incident cases of Acute Respiratory Distress Syndrome in Germany
    France
    Incident cases of Acute Respiratory Distress Syndrome in France
    Sub-type (Mild and Moderate) specific incident cases of Acute Respiratory Distress Syndrome in France
    Italy
    Incident cases of Acute Respiratory Distress Syndrome in Italy
    Sub-type (Mild and Moderate) specific incident cases of Acute Respiratory Distress Syndrome in Italy
    Spain
    Incident cases of Acute Respiratory Distress Syndrome in Spain
    Sub-type (Mild and Moderate) specific incident cases of Acute Respiratory Distress Syndrome in Spain
    Japan
    Incident cases of Acute Respiratory Distress Syndrome in Japan
    Sub-type (Mild and Moderate) specific incident cases of Acute Respiratory Distress Syndrome in Japan
    Treatment Algorithm
    Current Unmet Needs
    Emerging Therapies (Phase-III)
    Interferon beta-1a: Faron Pharmaceuticals
    Description
    Regulatory Milestones
    Clinical Development
    Clinical Trial by Phase
    Safety and Efficacy
    Global ARDS: Country-Wise Market Analysis
    Total Market Size of ARDS (2013-2023)
    United States
    United Kingdom
    Germany
    France
    Italy
    Spain
    Japan
    Market Drivers
    Market Barriers
    Appendix
    Report Methodology
    Consulting Services
    Disclaimer
    About DelveInsight
    Table 1:Comparison Between American-European Consensus Conference (AECC) definition and the Berlin definition
    Table 2: Incident Cases of ARDS in United States (2013-2023)
    Table 3: Sub types Specific Cases of ARDS in United States (2013-2023)
    Table 4: Incident Cases of ARDS in United Kingdom (2013-2023)
    Table 5: Sub types Specific Cases of ARDS in United Kingdom (2013-2023)
    Table 6: Incident Cases of ARDS in Germany (2013-2023)
    Table 7: Sub types Specific Cases of ARDS in Germany (2013-2023)
    Table 8: Incident Cases of ARDS in France (2013-2023)
    Table 9: Sub types Specific Cases of ARDS in France (2013-2023)
    Table 10: Incident Cases of ARDS in Italy (2013-2023)
    Table 11: Sub types Specific Cases of ARDS in Italy (2013-2023)
    Table 12:Incident Cases of ARDS in Spain (2013-2023)
    Table 13: Sub types Specific Cases of ARDS in Spain (2013-2023)
    Table 14: Incident Cases of ARDS in Japan (2013-2023)
    Table 15: Incident, Diagnosed and Treatable cases of ARDS in Japan (2013-2023)
    Table 16: Total Market size of ARDS in USD Million (2013-2023)
    Table 17: United States Market Size of ARDS in USD, Million (2020-2019)
    Table 18: United Kingdom Market Size of ARDS in USD, Billion (2013-2023)
    Table 19: Germany Market Size of ARDS in USD, Million (2013-2023)
    Table 20: France Market Size of ARDS in USD, Million (2013-2023)
    Table 21: Italy Market Size of ARDS in USD, Million (2013-2023)
    Table 22: Spain Market Size of ARDS in USD, Million (2013-2023)
    Table 23:Japan Market Size of ARDS in USD, Million (2013-2023)
    Figure 1: Normal Alveolus and injured alveolus during Acute Respiratory Distress Syndrome
    Figure 2: Risk factors of Acute Respiratory Distress Syndrome
    Figure 3: Incident Population of ARDS in United States (2013-2023)
    Figure 4: Sub types Specific Cases of ARDS in United States (2013-2023)
    Figure 5: Incident Population of ARDS in United Kingdom (2013-2023)
    Figure 6 Sub types Specific Cases of ARDS in United Kingdom (2013-2023)
    Figure 7: Incident Cases of ARDS in Germany (2013-2023)
    Figure 8: Sub types Specific Cases of ARDS in Germany (2013-2023)
    Figure 9: Incident Cases of ARDS in France (2013-2023)
    Figure 10: Sub types Specific Cases of ARDS in France (2013-2023)
    Figure 11: Incident Cases of ARDS in Italy (2013-2023)
    Figure 12: Sub types Specific Cases of ARDS in Italy (2013-2023)
    Figure 13: Incident Cases of ARDS in Spain (2013-2023)
    Figure 14: Sub types Specific Cases of ARDS in Spain (2013-2023)
    Figure 15: Incident Population of ARDS in Japan (2013-2023)
    Figure 16: Sub types Specific Cases of ARDS in Japan (2013-2023)
    Figure 17: Treatment Algorithm, 2016
    Figure 18: Current Unmet Needs of Acute Respiratory Distress Syndrome (ARDS)
    Figure 19: Total Market Size of ARDS in USD, Billion (2013-2023)
    Figure 20: Total Market Size of ARDS in USD, billion (2013-2023)
    Figure 21: United States Market Size of ARDS in USD, Million (2013-2019)
    Figure 22: United States Market Size of ARDS in USD, Million (2020-2023)
    Figure 23: United Kingdom Market Size of ARDS in USD, Million (2013-2018)
    Figure 24: United Kingdom Market Size of ARDS in USD, Million (2019-2023)
    Figure 25: Germany Market Size of ARDS USD, Million (2013-2018)
    Figure 26: Germany Market Size of ARDS USD, Million (2019-2023)
    Figure 27: France Market Size of ARDS in USD, Million (2013-2018)
    Figure 28: France Market Size of ARDS in USD, Million (2019-2023)
    Figure 29: Italy Market Size of ARDS in USD, Million (2013-2018)
    Figure 30: Italy Market Size of ARDS in USD, Million (2019-2023)
    Figure 31: Spain Market Size of ARDS in USD, Million (2013-2018)
    Figure 32: Spain Market Size of ARDS in USD, Million (2019-2023)
    Figure 33:Japan Market Size of ARDS in USD, Million (2013-2018)
    Figure 34:JapanMarket Size of ARDS in USD, Million (2019-2023)
    Acute Respiratory Distress Syndrome (ARDS) (CD) Market (7MM)

    Acute Respiratory Distress Syndrome (ARDS) (CD) Market forecasting

    Acute Respiratory Distress Syndrome (ARDS) (CD) Sales forecasting

    Acute Respiratory Distress Syndrome (ARDS) (CD) Market segments

    Acute Respiratory Distress Syndrome (ARDS) (CD) Epidemiology

    Acute Respiratory Distress Syndrome (ARDS) (CD) Pipeline products and technologies

    Acute Respiratory Distress Syndrome (ARDS) (CD) Competitive landscape

    Acute Respiratory Distress Syndrome (ARDS) (CD) SWOT analysis

    Acute Respiratory Distress Syndrome (ARDS) (CD) Market Driver's and barriers

    Acute Respiratory Distress Syndrome (ARDS) (CD) Key Companies and Funding



    • Single User License
      (20% Off)
      $4,950.00
      $3960
    • Site License
      (30% Off)
      $9,900.00
      $6930
    • Global License
      (40% Off)
      $14,850.00
      $8910

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap